Learn more about NYSCF’s latest announcements, statements and research breakthroughs.
Scientists from the New York Stem Cell Foundation (NYSCF) Research Institute have developed a new bone engineering technique called Segmental Additive Tissue Engineering (SATE). The technique,...
Two top scientific and business professionals recently joined NYSCF, bolstering its leadership team: Melissa J. Nirenberg, MD, PhD, FAAN has joined NYSCF as its inaugural Chief...
NYSCF welcomed six of the most talented stem cell researchers and neuroscientists from around the world into the NYSCF Investigator Program and the NYSCF Innovator Community....
Dr. Paul Tesar, a professor at Case Western Reserve University and NYSCF — Robertson Stem Cell Investigator Alumnus, is the 2017 recipient of the NYSCF –...
NYSCF and the Beyond Batten Disease Foundation (BBDF) partnered to create a unique and comprehensive collection of juvenile Batten (CLN3) disease induced pluripotent stem (iPS) cells....
Your body is full of immune cells that fight off infection and illness. You’ve probably heard of a few of them: white blood cells, B cells,...
NYSCF officially opened its new state-of-the-art Research Institute and headquarters in Manhattan. The expanded NYSCF Research Institute will allow scientists to conduct the most advanced stem...
A collaboration beginning in 2013 between the NYSCF Research Institute and the Personal Genome Project (PGP) has resulted in the availability of a unique new stem...
A team of researchers at Columbia University Medical Center including NYSCF – Robertson Investigator Dr. Dieter Egli have discovered that a specific enzyme deficiency in the brain...
Leaders in stem cell biology and researchers at the forefront of translational medicine convened at the 2016 NYSCF Conference to discuss the latest advances in using...
NYSCF announced today that Feng Zhang, PhD, is the 2016 recipient of the NYSCF – Robertson Stem Cell Prize for his pioneering advances to edit human...
NYSCF announced the 2016 class of NYSCF – Robertson Investigators, welcoming six of the most talented stem cell researchers and neuroscientists from around the world into...
A report in The New Scientist presents claims that the first baby was born in Mexico by a New York based doctor using mitochondrial replacement therapy...
The National Stem Cell Foundation (NSCF) and the NYSCF Research Institute announced that a grant from NSCF will be used to fund NYSCF research on cell...
The NYSCF Research Institute announced a new collaboration with Yumanity Therapeutics, a company focused on transforming drug discovery for diseases caused by protein misfiling, to generate...
Stem cell lines resulting from a pathbreaking collaboration beginning in 2014 between The NYSCF Research Institute and the Charcot-Marie-Tooth Association (CMTA) are now available for use...
NYSCF has been at the forefront of bringing mitochondrial replacement therapy to the clinic and in 2011, published a seminal paper in Nature that showed mitochondrial replacement could...
The NYSCF Research Institute is committed to accelerating research by sharing its expertise and leveraging its technologies with scientists at collaborating institutions around the world. A...
Normal human cells contain two copies of each gene – one inherited from a mother, and one from a father. An international collaboration of scientists including...
After marking it’s 10th Anniversary, NYSCF is excited to announce a move to the far west side after signing a multi-year lease for 42,000 square-feet at...
At The 2015 NYSCF Conference: Tenth Annual Translational Stem Cell Research Conference, NYSCF announced Franziska Michor. PhD, as the 2015 recipient of the Robertson Stem Cell...
Five new NYSCF – Robertson Investigators join the prestigious community of early career scientists making the transition from post-doctoral research to their own labs. The three...
At the 10th Annual NYSCF Conference on Translational Stem Cell Research NYSCF will bring together world leaders in biotechnology, regenerative medicine, precision medicine, and pharmaceuticals to...
NYSCF and CBR Systems, Inc. DBA Cord Blood Registry (CBR) are collaborating to customize the creation of high-quality stem cell lines from umbilical cord blood tissue....
NYSCF announces a new partnership with Q-State Biosciences (Q-State) to generate high quality stem cells from patient blood cells. The collaboration will mark the first time...
